Coronavirus Vaccine: India made potential vaccine gets human trial approval

COVAXIN, India’s first potential vaccine for COVID-19, has received nod for human trials for Phase I and II from drug regulator DGCI. This vaccine has been developed by Bharat Biotech. Vaccine trials on humans are planned to begin in July this year.

This vaccine has been developed in collaboration with the Indian Institute of Medical Research (ICMR) and the National Institute of Virology (NIV). The strain of the virus was Isolated at NIV, Pune and sent to Bharat Biotech, where the indigenous vaccine was developed.

More than 100 vaccines of coronavirus are currently under operation worldwide, but still no success in this field. Today, a vaccine was allowed to be used in China today as well. This vaccine has been developed by the Research Unit of the Chinese Army and the Cansino Biologics. This Ad5-nCoV vaccine is one of the eight possible Chinese vaccines that have been approved for trials on humans. However, Cansino said that the vaccine will be for military use only because it cannot be used on a large scale without the permission of the Department of Logistics.